BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 26473261)

  • 1. Cherubism Study Results May Apply to Common Inflammatory Bone Diseases.
    Dent Today; 2015 May; 34(5):54. PubMed ID: 26473261
    [No Abstract]   [Full Text] [Related]  

  • 2. Jawing about TNF: new hope for cherubism.
    Novack DV; Faccio R
    Cell; 2007 Jan; 128(1):15-7. PubMed ID: 17218248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel treatment of a rare genetic bone disease.
    McMahon MS
    Orthopedics; 2007 Feb; 30(2):91. PubMed ID: 17323628
    [No Abstract]   [Full Text] [Related]  

  • 4. Etanercept administration to neonatal SH3BP2 knock-in cherubism mice prevents TNF-α-induced inflammation and bone loss.
    Yoshitaka T; Ishida S; Mukai T; Kittaka M; Reichenberger EJ; Ueki Y
    J Bone Miner Res; 2014; 29(5):1170-82. PubMed ID: 24978678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular and Cellular Pathogenesis of Cherubism].
    Ueki Y
    Clin Calcium; 2016 Jun; 26(6):918-26. PubMed ID: 27230848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of Tankyrase-mediated destruction of 3BP2 is the underlying pathogenic mechanism of cherubism.
    Levaot N; Voytyuk O; Dimitriou I; Sircoulomb F; Chandrakumar A; Deckert M; Krzyzanowski PM; Scotter A; Gu S; Janmohamed S; Cong F; Simoncic PD; Ueki Y; La Rose J; Rottapel R
    Cell; 2011 Dec; 147(6):1324-39. PubMed ID: 22153076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gene mutation and expression of SH-3BP-2 in cherubism].
    Li YW; Meng XM; Yu SF; Gao P
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2009 Apr; 44(4):227-31. PubMed ID: 19576004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-tumor necrosis factor treatment in cherubism--clinical, radiological and histological findings in two children.
    Hero M; Suomalainen A; Hagström J; Stoor P; Kontio R; Alapulli H; Arte S; Toiviainen-Salo S; Lahdenne P; Mäkitie O
    Bone; 2013 Jan; 52(1):347-53. PubMed ID: 23069372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SH3BP2 is rarely mutated in exon 9 in giant cell lesions outside cherubism.
    Lietman SA; Prescott NL; Hicks DG; Westra WH; Levine MA
    Clin Orthop Relat Res; 2007 Jun; 459():22-7. PubMed ID: 17545756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel mutation of SH3BP2 in cherubism and demonstration that SH3BP2 mutations lead to increased NFAT activation.
    Lietman SA; Kalinchinko N; Deng X; Kohanski R; Levine MA
    Hum Mutat; 2006 Jul; 27(7):717-8. PubMed ID: 16786512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NFATc1 and TNFalpha expression in giant cell lesions of the jaws.
    Amaral FR; Brito JA; Perdigão PF; Carvalho VM; de Souza PE; Gomez MV; De Marco L; Gomez RS
    J Oral Pathol Med; 2010 Mar; 39(3):269-74. PubMed ID: 20002873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imatinib has minimal effects on inflammatory and osteopenic phenotypes in a murine cherubism model.
    Mukai T; Akagi T; Hiramatsu Asano S; Tosa I; Ono M; Kittaka M; Ueki Y; Yahagi A; Iseki M; Oohashi T; Ishihara K; Morita Y
    Oral Dis; 2023 Apr; 29(3):1089-1101. PubMed ID: 34743383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The adapter 3BP2: how it plugs into leukocyte signaling.
    Deckert M; Rottapel R
    Adv Exp Med Biol; 2006; 584():107-14. PubMed ID: 16802602
    [No Abstract]   [Full Text] [Related]  

  • 14. A novel mutation of the SH3BP2 gene in an aggressive case of cherubism.
    Carvalho VM; Perdigão PF; Pimenta FJ; de Souza PE; Gomez RS; De Marco L
    Oral Oncol; 2008 Feb; 44(2):153-5. PubMed ID: 17368082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism.
    Ueki Y; Tiziani V; Santanna C; Fukai N; Maulik C; Garfinkle J; Ninomiya C; doAmaral C; Peters H; Habal M; Rhee-Morris L; Doss JB; Kreiborg S; Olsen BR; Reichenberger E
    Nat Genet; 2001 Jun; 28(2):125-6. PubMed ID: 11381256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [SH3BP2 heterozygous mutation amplifies macrophage inflammatory responses to infection in a mouse model of cherubism].
    Deckert M; Prod'Homme V
    Med Sci (Paris); 2015; 31(6-7):589-91. PubMed ID: 26152156
    [No Abstract]   [Full Text] [Related]  

  • 17. Novel nucleotide mutation leading to a recurrent amino acid alteration in SH3BP2 in a patient with cherubism.
    Sangu N; Shimosato T; Inoda H; Shimada S; Shimojima K; Ando T; Yamamoto T
    Congenit Anom (Kyoto); 2013 Dec; 53(4):166-9. PubMed ID: 24712477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mutation detection in SH3BP2 gene in a cherubism family].
    Li CY; Yu SF
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2006 Jun; 41(6):368-71. PubMed ID: 16836910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetic aspects of cherubism].
    Brix M; Peters H; Ranfaing E; Ricbourg B
    Rev Stomatol Chir Maxillofac; 2006 Apr; 107(2):105-8. PubMed ID: 16738517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new mutation in the SH3BP2 gene showing reduced penetrance in a family affected with cherubism.
    de Lange J; van Maarle MC; van den Akker HP; Redeker EJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):378-81. PubMed ID: 17321449
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.